Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FISV
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 1.81 1.06 1.04
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 16.65 11.94 10.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.95 48.74 49.71
Cash 2.49 2.05 2.00
Capex -20.60 -0.71 -0.59
Free Cash Flow -65.26 0.73 2.11
Revenue 0.94 8.26 8.19
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -20.56 0.59 0.74
Operating Margin -18.11 0.24 0.30
ROA -17.17 < 0.005 < 0.005
ROE -12.42 0.03 0.03
ROIC -16.43 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FISV is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FISV is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FISV is permitted for members.